Abstract 1 AMP-activated protein kinase (AMPK) is a key molecular player in energy 2 homeostasis both at cellular and whole body levels. AMPK has been shown to 3 mediate the metabolic effects of hormones such as leptin, ghrelin, adiponectin, 4 glucocorticoids and insulin as well as cannabinoids. Generally, activated AMPK 5 stimulates catabolic pathways (glycolysis, fatty acid oxidation and mitochondrial 6 biogenesis) and inhibits anabolic pathways (gluconeogenesis, glycogen, fatty acid and 7 protein synthesis) and has a direct appetite-regulating effect in the hypothalamus. 8
1
Introduction 2 AMP-activated protein kinase (AMPK) has emerged as a key molecular player 3 in energy homeostasis both at cellular and whole body levels (Kahn, et al. 2005) . 4 Initially AMPK was shown to have lipid-related effects: it inactivates acetyl-CoA 5 carboxylase (ACC) (Carlson and Kim 1973) and 3-hydroxy-3-methylglutaryl (HMG) -6 CoA reductase (Beg, et al. 1973) , the key regulatory enzymes of fatty acid and 7 cholesterol synthesis. Later the role of AMPK in carbohydrate and protein metabolism, 8 cell cycle regulation and mitochondrial biogenesis were also described. AMPK is an 9 evolutionarily-conserved serine/threonine kinase with a catalytic α subunit and 10 regulatory β and γ subunits, forming a heterotrimeric complex. The upstream 11 regulation of AMPK is summarised in Figure 1 and agouti-related peptide (AgRP) mRNA levels in the arcuate nucleus (ARC) under 2 ad libitum fed conditions. In contrast, CA-AMPK-adenovirus treated mice ate 3 significantly more and had higher body weight with increased expression of NPY and 4
AgRP mRNA in ARC, as well as increased orexigenic melanin concentrating 5 hormone (MCH) expression in lateral hypothalamus. This suggests that high AMPK 6 activity enhances orexigenic signals, whereas low AMPK activity suppresses these 7 signals under ad libitum fed conditions. In agreement with this, deletion of AMPKα2 8 in AgRP neurons led to the development of an age-dependent lean phenotype. 9
Peripheral hormones from the gastrointestinal tract (peptide YY, ghrelin, 10 cholecystokinin, glucagon-like peptide 1, and oxyntomodulin) and adipose tissue 11 rodents showed a decreased AMPK activity in the liver (Yu, et al. 2004 ). In lean 17 animals, leptin has been shown to attenuate hepatic glucose production and insulin 18 resistance under normal conditions and to slightly increase AMPK activity (Brabant, 19 et al. 2005) . However, these effects are lost in diet-induced obese rats, thereby 20
suggesting an important physiological dysregulation of leptin effects in obese animals. 21
Leptin inhibits triacylglycerol storage and stimulates fatty acid oxidation in the heart, Glucocorticoids also inhibited AMPK activity in the heart, which might, at least in 24 part, mediate the detrimental effects of glucocorticoid excess on the heart. 25 Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, 22 Pfluger 
Declaration of Interest 16

References
